The PDA Midwest Chapter is pleased to have a presentation on CCS Development in Pharmaceutical Manufacturing.
With Annex 1 approved and implementation required by 25-Aug-2023 (for most requirements), many organizations are feverishly working on establishing a robust Contamination Control Strategy (CCS) for contamination prevention. Join us for this timely and informative webinar providing insight and answering questions on PDA Technical Report No. 90 entitled "Contamination Control Strategy Development in Pharmaceutical Manufacturing."
Frederic Ayers, Advisor, Sterility Assurance- Parenteral Products Network and PDA TR 90 Taskforce Member